Mater Misericordiae University Hospital

Dublin, Co Dublin 7

0 studies enrolling now · 6 studies all time

What they study most

Breast Adenocarcinoma, Breast Ductal Carcinoma In Situ, HER2/Neu Positive, Hormone Receptor Positive, Invasive Breast Carcinoma, Light Chain Deposition Disease, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Recurrent Prostate Carcinoma, Smoldering Multiple Myeloma

Studies at this site

• Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma — Running, not enrolling
• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer — Running, not enrolling
• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer — Completed
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery — Completed
• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer — Completed